Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Using Acetazolamide to Treat Obstructive Sleep Apnea

Official title: Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea

Run by University of California, San Diego · NCT05804084 · Data updated 2026-11-12

This study is testing if a medication called acetazolamide can help adults with moderate to severe obstructive sleep apnea breathe better at night and feel more rested during the day.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations1 site (La Jolla, California)
StatusRecruiting
StartedMay 16, 2023
Main results expectedOctober 31, 2026
Study endsOctober 31, 2026
Registry record updatedMay 8, 2026
Trial IDNCT05804084 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with untreated moderate to severe obstructive sleep apnea and a body mass index of 35 kg/m2 or less.

Probably not a fit

Patients with significant sleep hypoxemia, other major sleep disorders, or those requiring immediate OSA therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of acetazolamide, a mild diuretic, in treating adults with moderate to severe obstructive sleep apnea (OSA). Participants will be randomly assigned to receive either acetazolamide or a placebo for four weeks, during which their sleep patterns and neurocognitive functions will be monitored. The study will include eligibility screenings, in-person assessments, and an overnight sleep test to ensure participants meet the criteria. The primary goals are to determine if acetazolamide improves OSA symptoms and enhances quality of life compared to placebo.

Why it matters

Potential benefit: If successful, this treatment could provide a new, effective, and well-tolerated option for patients suffering from obstructive sleep apnea.

How similar studies have gone: While acetazolamide has been used for various conditions, this specific application for obstructive sleep apnea is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Body mass index ≤ 35 kg/m2
* Untreated moderate/severe OSA (AHI ≥15/h)

Exclusion Criteria:

* Substantial sleep hypoxemia (SpO2\<80% for \>10% of the monitoring time during the home sleep test, or for \>25% of the total sleep time during any of the in-laboratory studies)
* Abnormally low blood counts/electrolytes or renal function at baseline
* Use of OSA therapy during the past 1 month, or plans to urgently resume/(re)start clinical OSA therapy within 3 months
* Significant, uncontrolled cardiac, pulmonary, endocrine, renal, hepatic, neurocognitive, psychiatric, or urologic (e.g., kidney stones) disorder
* Other major sleep disorder (e.g., narcolepsy)
* Urgent need to initiate effective OSA therapy (i.e., Epworth sleepiness score \>18, commercial driver, prior sleep-related car accident, or based on MD judgment)
* Severe allergy to sulfa-drugs or taking another carbonic-anhydrase inhibitor (e.g., topiramate)
* Pregnancy/breastfeeding (current/planned)
* Prisoners
* Illicit substance abuse or \>2 standard drinks of alcohol/day
* Medications that may affect OSA or ventilatory control (e.g., opiates, sedatives)
* Thiazide/loop diuretic (risk of hypokalemia)
* Inability to give consent or follow procedures
* Safety concern based on MD judgment

Where it's running

  • UC San Diego; Altman Clinical and Translational Research Institute Building
    La Jolla, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.